Streetbeat News

Products Services

ANGH

DKS

SHOT

Dick's Sporting Goods reported an increase in Q3 adjusted EPS to $2.85 from $2.60 year-over-year, with sales rising to $3.04B from $2.96B. Anghami received a commitment for up to $50M cash investment from OSN Group at a valuation of $3.65 per share, which will give OSN a majority stake. Safety Shot announced a West Coast launch in California on December 7th.

Portfolio Pulse from ryanfaloona@benzinga.com

November 21, 2023 | 1:49 pm

BIDU

FXI

SPY

Baidu's CEO anticipates that U.S. sanctions will affect China's AI development in the long term. During a conference call, the CEO mentioned that Baidu is actively looking for alternatives to mitigate the impact of these sanctions.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 1:41 pm

DXC

HBI

DXC Technology (NYSE:DXC) has signed a five-year contract with HanesBrands (NYSE:HBI) to enhance the work experience of HanesBrands' global workforce through Modern Workplace solutions. The partnership, an extension of their existing multi-year global collaboration, will leverage ServiceNow and DXC UPTimeTM Device Management technologies to improve productivity, connectivity, and efficiency across HanesBrands' operations in 32 countries. The digital transformation aims to facilitate better collaboration among HanesBrands' 51,000 associates worldwide and drive business growth by becoming a more digital and data-driven enterprise.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 1:34 pm

JAGX

Napo Pharmaceuticals, part of Jaguar Health, Inc. (NASDAQ:JAGX), has announced that top line data from its Phase 3 OnTarget trial for crofelemer, a drug for preventing diarrhea in cancer patients, is forthcoming. The trial results are still blinded to the company and key personnel. The trial's abstract has been accepted for presentation at the San Antonio Breast Cancer Symposium in December 2023. Crofelemer is a plant-based drug approved under FDA botanical guidance, and the trial aims to address the unmet need for treatment of chemotherapy-induced overactive bowel (CIOB).

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 1:33 pm

ABVC

ABVC BioPharma has been granted a U.S. patent for PDC-1421, a treatment for ADHD. The patent application number is 17/120,965. This development could potentially enhance ABVC's intellectual property portfolio and provide a competitive edge in the ADHD treatment market.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 1:32 pm

AAPL

Analyst Ming-chi Kuo predicts that Apple Inc. (AAPL) will include a periscope lens in the iPhone 16 Pro model, not just the Pro Max, due to improved manufacturing yields by Largan. This marks a strategy shift for Apple, potentially making high-end camera features more accessible. Largan's increased yields, now at 70%, make the lens assembly more cost-effective, supporting a projected 160% YoY growth in iPhones with this camera in 2024. The prediction is based on solid yield rate data, but the inclusion in the iPhone 16 Pro remains speculative.

Portfolio Pulse from Benzinga Neuro

November 21, 2023 | 1:27 pm

GEN

ONDS

PRCH

TSM

Four tech stocks in the information technology sector are showing overbought signals according to their Relative Strength Index (RSI) values, which could be a warning to momentum investors. Ondas Holdings Inc. (ONDS) reported a narrower-than-expected quarterly loss and achieved record revenue, with an RSI of 82.79. Gen Digital Inc. (GEN) reported better-than-expected sales and has an RSI of 77.80. Porch Group, Inc. (PRCH) also reported better-than-expected sales with an RSI of 76.58. Taiwan Semiconductor Manufacturing Company Limited (TSM) is considering a new advanced chipmaking plant in Japan and has an RSI of 72.15.

Portfolio Pulse from Lisa Levin

November 21, 2023 | 1:26 pm

WMT

Walmart partners with Bamboo Rose to develop a new enterprise sourcing platform (ESP) to revolutionize its global sourcing operations. The ESP will integrate various systems, enhance efficiency, and support Walmart's commitment to low-cost goods. It will enable better collaboration among Walmart's sourcing associates, buyers, product development teams, and suppliers, leading to more informed purchasing decisions, improved market access, and reduced waste, especially in perishable goods. The initiative aligns with Walmart's strategy to save money for customers and is expected to impact all markets and business units, including Sam's Club.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 1:19 pm

ORTX

The US FDA has decided not to schedule an advisory committee meeting for Orchard Therapeutics' Biologics License Application for OTL-200, intended to treat Metachromatic Leukodystrophy, according to a recent SEC filing.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 1:13 pm

BAER

Bridger Aerospace Group Holdings, Inc. (NASDAQ: BAER, BAERW) has entered into a joint venture partnership with Marathon Asset Management LP and Avenue Sustainable Solutions Fund to purchase four Canadair CL-215T Amphibious Aircraft from the Spanish government for €40.3 million. The acquisition is expected to close in ten business days and is seen as a strategic move to expand Bridger's customer base and create substantial revenue and cash flow growth. Bridger will manage the upgrades of the planes and has the right to acquire them sequentially as they are ready for service, with the first two expected to be operational by Summer 2024 in the EU.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 1:10 pm